ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Why Real-Time eCOA Data Matters More Than Ever

  Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.

• How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?

  Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?

• Beginner's Guide To 21 CFR Part 11 Compliance

  Computer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. While Part 11 is widely known, this blog explains how it fits in with your research software.

• Shaping The Future Of Clinical Trial Technology With tPlatform Unification

  As we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification.

• 8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development

  Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.

• The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials

  Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.

• Addressing The Challenges Of eCOA Licensing

  How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?

• eCOA/ePRO: Why Patients Deserve Even More Progress

  The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.

• Automated Trial Monitoring Workflows Make A Lean Team More Efficient

  A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.

• The Future Of AI In Clinical Research, Delivered Today

  The FDA's new guidance outlines a future where AI models support regulatory submissions, taking a pivotal step toward modernizing regulatory science.